LivaNova PLC

NASDAQ:LIVN USA Medical Devices
Market Cap
$3.41 Billion
Market Cap Rank
#3815 Global
#2444 in USA
Share Price
$62.43
Change (1 day)
+1.63%
52-Week Range
$33.85 - $71.00
All Time High
$130.95
About

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing syste… Read more

LivaNova PLC (LIVN) - Total Liabilities

Latest total liabilities as of September 2025: $1.40 Billion USD

Based on the latest financial reports, LivaNova PLC (LIVN) has total liabilities worth $1.40 Billion USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

LivaNova PLC - Total Liabilities Trend (1992–2024)

This chart illustrates how LivaNova PLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

LivaNova PLC Competitors by Total Liabilities

The table below lists competitors of LivaNova PLC ranked by their total liabilities.

Liability Composition Analysis (1992–2024)

This chart breaks down LivaNova PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.55 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how LivaNova PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for LivaNova PLC (1992–2024)

The table below shows the annual total liabilities of LivaNova PLC from 1992 to 2024.

Year Total Liabilities Change
2024-12-31 $1.19 Billion +2.97%
2023-12-31 $1.15 Billion +5.96%
2022-12-31 $1.09 Billion +19.95%
2021-12-31 $906.31 Million -29.78%
2020-12-31 $1.29 Billion +25.54%
2019-12-31 $1.03 Billion -1.71%
2018-12-31 $1.05 Billion +51.90%
2017-12-31 $688.60 Million +8.32%
2016-12-31 $635.70 Million -14.93%
2015-12-31 $747.28 Million +2029.51%
2014-12-31 $35.09 Million 0.00%
2013-12-31 $35.09 Million +1.79%
2012-12-31 $34.48 Million +21.23%
2011-12-31 $28.44 Million -21.04%
2010-12-31 $36.02 Million +5.31%
2009-12-31 $34.20 Million -27.96%
2008-12-31 $47.47 Million -46.98%
2007-12-31 $89.53 Million -40.72%
2006-12-31 $151.05 Million +2.29%
2005-12-31 $147.67 Million +534.88%
2004-12-31 $23.26 Million -8.12%
2003-12-31 $25.32 Million -8.55%
2002-12-31 $27.68 Million +3.02%
2001-12-31 $26.87 Million +6.95%
2000-12-31 $25.12 Million +95.58%
1999-12-31 $12.85 Million +100.72%
1998-12-31 $6.40 Million +23.08%
1997-12-31 $5.20 Million +36.84%
1996-12-31 $3.80 Million +58.33%
1995-12-31 $2.40 Million -17.24%
1994-12-31 $2.90 Million +123.08%
1993-12-31 $1.30 Million +18.18%
1992-12-31 $1.10 Million --